Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kits EyecareKTYCF +2.94%73 Days Sales Outstanding is 5.97 as of Mar. 2026, which is 50% above its 10-year median of 3.98. GuruFocus rates KTYCF with a GF Score™ of 73/100 and a GF Value™ of $9.68 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,105 Retail - Cyclical companies, Kits Eyecare ranks better than 81.09% on this metric.
Kits Eyecare's average Accounts Receivable for the
three
months ended in Mar. 2026 was $2.7 Mil. Kits Eyecare's Revenue for the
three
months ended in Mar. 2026 was $41.9 Mil.
Hence, Kits Eyecare's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 5.97.
The historical rank and industry rank for Kits Eyecare's Days Sales Outstanding or its related term are showing as below:
KTYCF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.57 Med: 3.98 Max: 8.36
Current: 4.82
During the past 8 years, Kits Eyecare's highest Days Sales Outstanding was 8.36. The lowest was 2.57. And the median was 3.98.
KTYCF's Days Sales Outstanding is ranked better than 81.09% of 1105
companies
in the Retail - Cyclical industry
Industry Median: 18.58
vs KTYCF: 4.82
Kits Eyecare's Days Sales Outstanding
increased
from Mar. 2025 (4.02) to Mar. 2026 (5.97).
Kits Eyecare (OTCPK:KTYCF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Kits Eyecare Days Sales Outstanding Related Terms
Kits Eyecare Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Kits Eyecare's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KTYCF vs CASY, WSM, ULTA: Days Sales Outstanding Comparison
For the Specialty Retail subindustry, Kits Eyecare's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kits Eyecare Days Sales Outstanding vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Kits Eyecare's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kits Eyecare (KTYCF) has a Days Sales Outstanding of 5.97 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Kits Eyecare and its competitors. This is 50% above median its historical median of 3.98. Over the past decade, Kits Eyecare's Days Sales Outstanding has ranged from 2.57 to 8.36. According to the industry distribution chart, Kits Eyecare ranks #209 out of 1105 companies in the Retail - Cyclical industry, placing it in the top 18.9%.
Is Kits Eyecare's Days Sales Outstanding too high?
Kits Eyecare's current Days Sales Outstanding of 5.97 is 50% above median its 10-year median of 3.98. Over the past 10 years, this metric has ranged from a low of 2.57 to a high of 8.36. The Retail - Cyclical industry median Days Sales Outstanding is 18.58. Kits Eyecare's value of 5.97 is 67.9% below this industry median. Based on the distribution chart, Kits Eyecare ranks #209 out of 1105 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Kits Eyecare has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's Days Sales Outstanding compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Kits Eyecare ranks #209 out of 1105 companies for Days Sales Outstanding. This places Kits Eyecare in the top 19% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 18.58. Kits Eyecare's value of 5.97 is 67.9% below this benchmark. Historically, Kits Eyecare's own Days Sales Outstanding has ranged from 2.57 to 8.36 over the past decade. While the company's 10-year median is 3.98 vs. the industry median of 18.58, Kits Eyecare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Retail - Cyclical company?
The median Days Sales Outstanding among Retail - Cyclical companies is 18.58, based on 1,105 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kits Eyecare's current Days Sales Outstanding of 5.97 is 67.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Kits Eyecare and its competitors. For the Retail - Cyclical industry, the median Days Sales Outstanding is 18.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kits Eyecare's current Days Sales Outstanding is 5.97, which is 50% above median its own 10-year median of 3.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Fairly Valued. The stock's GF Value™ is $9.68, compared to a current price of $10.14 — trading 4.8% above its estimated fair value. The current Days Sales Outstanding is 5.97, which is 50% above median its 10-year median of 3.98 and 67.9% below the Retail - Cyclical industry median of 18.58. Kits Eyecare's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current Days Sales Outstanding is 5.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kits Eyecare (KTYCF) Overvalued in 2026?
Based on GuruFocus' analysis, Kits Eyecare stock appears to be overvalued.
The current stock price of $10.14 is trading 4.8% above its estimated GF Value™ of $9.68.
GuruFocus considers Kits Eyecare to be Fairly Valued.
Key valuation signals for KTYCF:
Days Sales Outstanding: 5.97 (50% above median its 10-year median of 3.98)
GF Value™: $9.68 vs. price of $10.14 (4.8% above fair value)
Industry Position: 67.9% below the Retail - Cyclical median (#209 of 1105)
No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
73GF Score
Get the complete analysis for KTYCF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KTYCF has been successfully added to your 
